Rebecca Bilton

988 total citations
21 papers, 785 citations indexed

About

Rebecca Bilton is a scholar working on Geriatrics and Gerontology, Molecular Biology and Cancer Research. According to data from OpenAlex, Rebecca Bilton has authored 21 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Geriatrics and Gerontology, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Rebecca Bilton's work include Cancer, Hypoxia, and Metabolism (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Frailty in Older Adults (6 papers). Rebecca Bilton is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Frailty in Older Adults (6 papers). Rebecca Bilton collaborates with scholars based in Australia, France and United States. Rebecca Bilton's co-authors include Grant W. Booker, Jacques Pouysségur, M. Christiane Brahimi-Horn, Nathalie M. Mazure, Eric Trottier, Frédéric Dayan, Jeffrey J. Gorman, Sarah E. Wilkins, Daniel J. Peet and Edurne Berra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Rebecca Bilton

18 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Bilton Australia 12 440 431 102 97 83 21 785
Esmeralda Castelblanco Spain 19 314 0.7× 167 0.4× 117 1.1× 132 1.4× 94 1.1× 70 1.1k
Olav Dajani Norway 17 336 0.8× 115 0.3× 38 0.4× 212 2.2× 77 0.9× 39 718
Scott A. Fraser Australia 21 599 1.4× 87 0.2× 49 0.5× 53 0.5× 125 1.5× 32 1.0k
Chun Gong China 18 631 1.4× 185 0.4× 86 0.8× 268 2.8× 58 0.7× 30 1.0k
David Seo United States 17 361 0.8× 119 0.3× 127 1.2× 47 0.5× 97 1.2× 41 885
Ryoichi Asaka Japan 15 297 0.7× 158 0.4× 26 0.3× 88 0.9× 38 0.5× 38 634
Krishna Seshu Tummala Spain 8 286 0.7× 101 0.2× 60 0.6× 158 1.6× 60 0.7× 9 727
Maria P. Martinez Cantarin United States 11 445 1.0× 320 0.7× 17 0.2× 174 1.8× 111 1.3× 22 861
Elizabeth A. McGuire United States 12 434 1.0× 101 0.2× 77 0.8× 159 1.6× 50 0.6× 18 1.1k

Countries citing papers authored by Rebecca Bilton

Since Specialization
Citations

This map shows the geographic impact of Rebecca Bilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Bilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Bilton more than expected).

Fields of papers citing papers by Rebecca Bilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Bilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Bilton. The network helps show where Rebecca Bilton may publish in the future.

Co-authorship network of co-authors of Rebecca Bilton

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Bilton. A scholar is included among the top collaborators of Rebecca Bilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Bilton. Rebecca Bilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lim, Renly, Rebecca Bilton, Gereltuya Dorj, et al.. (2023). Pharmacists as patient advocates: A series of case studies illustrating the impacts of a regular pharmacist service in residential aged care (nursing homes). SHILAP Revista de lepidopterología. 10. 100268–100268. 3 indexed citations
3.
Murray, Carolyn, Steve Milanese, Michelle Guerin, et al.. (2023). Exploring what matters to residents of Australian aged care facilities with the Happy Life Index: comparison of qualitative responses between pre- and mid-Covid-19 pandemic time points. Quality of Life Research. 32(8). 2247–2257. 1 indexed citations
4.
Ellett, Lisa Kalisch, Gereltuya Dorj, André Q Andrade, et al.. (2023). Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR Trial. Drug Safety. 46(5). 493–500. 4 indexed citations
5.
6.
Andrade, André Q, Renly Lim, Thu‐Lan Kelly, et al.. (2023). Correlation of frailty assessment metrics in one-year follow-up of aged care residents: a sub-study of a randomised controlled trial. Aging Clinical and Experimental Research. 35(10). 2081–2087.
7.
Dorj, Gereltuya, Nibu Parameswaran Nair, Lre Bereznicki, et al.. (2022). Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial. Drugs & Aging. 40(1). 49–58. 6 indexed citations
8.
Lim, Renly, Thu‐Lan Kelly, André Q Andrade, et al.. (2022). Frailty trajectory over one year among residential aged care (nursing home) residents. Frontiers in Medicine. 9. 1010444–1010444. 3 indexed citations
9.
Dorj, Gereltuya, Renly Lim, Lisa Kalisch Ellett, et al.. (2022). Medicine-related problems: A recurrent issue among residents living in nursing homes. Frontiers in Pharmacology. 13. 978871–978871.
10.
11.
Gnanamanickam, Emmanuel S., Suzanne M Dyer, Rachel Milte, et al.. (2018). Direct health and residential care costs of people living with dementia in Australian residential aged care. International Journal of Geriatric Psychiatry. 33(7). 859–866. 34 indexed citations
12.
Wilkins, Sarah E., Johana Chicher, Jeffrey J. Gorman, et al.. (2009). Differences in hydroxylation and binding of Notch and HIF-1α demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1). The International Journal of Biochemistry & Cell Biology. 41(7). 1563–1571. 48 indexed citations
13.
Zheng, Xiaofeng, José M. Dias, Xiaowei Zheng, et al.. (2008). Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proceedings of the National Academy of Sciences. 105(9). 3368–3373. 217 indexed citations
14.
Dayan, Frédéric, Rebecca Bilton, Julie Laferrière, et al.. (2008). Activation of HIF‐1α in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway. Journal of Cellular Physiology. 218(1). 167–174. 36 indexed citations
15.
Bilton, Rebecca, Eric Trottier, Jacques Pouysségur, & M. Christiane Brahimi-Horn. (2006). ARDent about acetylation and deacetylation in hypoxia signalling. Trends in Cell Biology. 16(12). 616–621. 29 indexed citations
16.
Bilton, Rebecca, Nathalie M. Mazure, Eric Trottier, et al.. (2005). Arrest-defective-1 Protein, an Acetyltransferase, Does Not Alter Stability of Hypoxia-inducible Factor (HIF)-1α and Is Not Induced by Hypoxia or HIF. Journal of Biological Chemistry. 280(35). 31132–31140. 87 indexed citations
17.
Mazure, Nathalie M., M. Christiane Brahimi-Horn, Mélanie Berta, et al.. (2004). HIF-1: master and commander of the hypoxic world. Biochemical Pharmacology. 68(6). 971–980. 120 indexed citations
18.
Bilton, Rebecca & Grant W. Booker. (2003). The subtle side to hypoxia inducible factor (HIFα) regulation. European Journal of Biochemistry. 270(5). 791–798. 119 indexed citations
19.
Whitmore, S.A., Joanna Crawford, Rebecca Bilton, et al.. (1999). Genomic structure and expression analysis of the spastic paraplegia gene, SPG7. Human Genetics. 105(1-2). 139–144. 21 indexed citations
20.
Whitmore, S.A., et al.. (1999). Genomic structure and expression analysis of the spastic paraplegia gene, SPG7. Human Genetics. 105(1-2). 139–144. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esmeralda Castelblanco Breakdown of academic impact, for papers by Olav Dajani Breakdown of academic impact, for papers by Scott A. Fraser Breakdown of academic impact, for papers by Chun Gong Breakdown of academic impact, for papers by David Seo Breakdown of academic impact, for papers by Ryoichi Asaka Breakdown of academic impact, for papers by Krishna Seshu Tummala Breakdown of academic impact, for papers by Maria P. Martinez Cantarin Breakdown of academic impact, for papers by Elizabeth A. McGuire
Rankless by CCL
2026